Picker International hopes a federal court judge's ruling thismonth has ended its eight-year legal battle with independent serviceorganization Imaging Equipment Services (IES) of Pittsburgh. Picker filed the litigation in 1987, accusing IES of
Picker International hopes a federal court judge's ruling thismonth has ended its eight-year legal battle with independent serviceorganization Imaging Equipment Services (IES) of Pittsburgh.
Picker filed the litigation in 1987, accusing IES of improperuse of service software and other charges. IES in turn chargedPicker with antitrust violations relating to scanner service.
Picker won a summary judgment ruling last year that threw outmany of the IES accusations (SCAN 6/15/94). In a ruling this month,U.S. District Court Judge Mark Wolf rejected the last of the ISO'scharges relating to intellectual property and issued a stingingrebuke to IES.
In a 73-page opinion, Wolf said IES "engaged in a relentlessand extensive campaign to misappropriate Picker's legally protectedintellectual property."
Wolf ordered IES to return or destroy Picker diagnostic softwareand service and repair documentation in its possession and permanentlyenjoined IES from violating Picker copyrights or misappropriatingPicker trade secrets. The judge appointed a monitor to ensurethat IES complies with the court's order.
A Picker spokesperson said the Cleveland vendor hopes thatWolf's ruling will be the last word on the case. IES plans toappeal the ruling to the U.S. Court of Appeals, according to IEScounsel Bill West.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.